HEMATOLOGY / RESEARCH PAPER
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
More details
Hide details
1
Department of Hematology,Xijing Hospital,Fourth Military Medical University, China
2
Department of Pharmacy, Daping Hospital, Third Military Medical University, China
Submission date: 2021-06-16
Final revision date: 2021-07-10
Acceptance date: 2021-07-18
Online publication date: 2021-07-27
Corresponding author
Yan-Hua Zheng
Department of Hematology,Xijing Hospital,Fourth Military Medical University, No.127 Chang’le West Road, 710032, Xi'an, China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Autophagy functions as a prosurvival mechanism in multiple myeloma (MM).The objective of this research was to establish an autophagy-related gene (ARG) signature for predicting the survival outcomes of MM patients with TP53 mutations.
Material and methods:
Information about MM patients with TP53 mutations was downloaded from Gene Expression Omnibus (GEO) database. Cox proportional hazard regression was employed to determine the independent prognostic ARG and construct a risk signature. Time-dependent receiver-operating characteristic (t ROC) curve was used to explore the predictive accuracy of the prognostic model. A nomogram was constructed to give a more precise prediction of the probability of 5-year, 8-year and 10-year overall survival (OS). In addition, we utilized the CIBERSORT algorithm to explore the distribution difference of 22 immune-infiltrating cells.
Results:
Three differentially expressed ARGs (CASP8, MAPK8, RB1CC1) were finally incorporated to construct the risk model. Area under the curve (AUC) of corresponding tROC curve for 5-year,8-year and 10-year OS were 0.735, 0.686 and 0.662, respectively. MM patients were categorized into high and low-risk group in accordance with the median threshold value (-1.724549). ARG-based risk score model was an independent prognostic element correlated with OS, giving an hazard ratio (HR) of 3.29 (95%CI 2.35-4.60, P<0.001). 13 immune infiltrating cells were found to have distribution differences between the two groups.
Conclusions:
We established a three-ARGs risk signature which manifested an independent prognostic factor. The nomogram was testified to perform well in forecasting the long-term survival of TP53-mutated MM patients.